Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.
about
Digitalis for treatment of heart failure in patients in sinus rhythmDigitalis for treatment of heart failure in patients in sinus rhythmSafety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataDigoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart FailureIntermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis.Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.DEFEAT heart failure: assessment and management of heart failure in nursing homes made easy.Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.Chronic heart failure in older adultsA propensity-matched study of low serum potassium and mortality in older adults with chronic heart failureDigoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureHeart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.Study of digoxin use in a public health unit.Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach
P2860
Q24194992-1573B1AC-FCB2-4A82-A88F-122EC69428ECQ24247158-4EECB4AB-7268-47D2-8521-388C39F6C1E6Q26796271-793EB06C-C40A-4EF5-90EB-1049E2AFCCB0Q33578694-83443622-0CD9-4112-92F4-81B8B43FC072Q33978533-391362E7-6D48-4D37-AD0F-D3E38D818C9AQ33997493-1CF9AC50-CFB7-4DFB-80DA-1E8BE8388BF2Q34445112-59B8A3B1-D56C-4943-A704-4CDEC2DA85A7Q34647669-9BB18D3E-5A90-4DFB-96D5-A9A82B074346Q36837740-C70F6A99-7C49-45D8-BE8D-61A2EF02FD5EQ36860117-A3D86561-CE0B-49BA-912F-BBBFD6B3DDB1Q37131540-33C8A329-4F74-463D-8D34-F01251CEECDEQ37407347-CAAA32E3-8C2A-4D40-A899-6B8D154F41CFQ37594550-6BE25BE8-65B2-437D-A0FC-22221B026660Q38127568-3208FAD1-46AC-4783-9304-BFA508DDDDDCQ41726747-9A3861CE-9443-4B74-BFB9-0849F6B3D7F1Q58766132-E1D853A9-F734-4E53-B22C-A69CCEC5D181
P2860
Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Digoxin and reduction in morta ...... and low serum concentrations.
@en
Digoxin and reduction in morta ...... and low serum concentrations.
@nl
type
label
Digoxin and reduction in morta ...... and low serum concentrations.
@en
Digoxin and reduction in morta ...... and low serum concentrations.
@nl
prefLabel
Digoxin and reduction in morta ...... and low serum concentrations.
@en
Digoxin and reduction in morta ...... and low serum concentrations.
@nl
P2860
P921
P356
P1476
Digoxin and reduction in morta ...... and low serum concentrations.
@en
P2093
P2860
P304
P356
10.1093/GERONA/62.3.323
P407
P577
2007-03-01T00:00:00Z